Growth Metrics

Core Laboratories (CLB) Non-Current Deferred Tax Liability (2022 - 2025)

Core Laboratories (CLB) has 4 years of Non-Current Deferred Tax Liability data on record, last reported at $10.1 million in Q3 2025.

  • For Q3 2025, Non-Current Deferred Tax Liability fell 25.43% year-over-year to $10.1 million; the TTM value through Sep 2025 reached $10.1 million, down 25.43%, while the annual FY2024 figure was $13.8 million, 8.55% up from the prior year.
  • Non-Current Deferred Tax Liability reached $10.1 million in Q3 2025 per CLB's latest filing, down from $11.5 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $22.9 million in Q4 2022 and bottomed at $9.9 million in Q1 2025.
  • Average Non-Current Deferred Tax Liability over 4 years is $13.1 million, with a median of $12.6 million recorded in 2024.
  • Peak YoY movement for Non-Current Deferred Tax Liability: crashed 44.5% in 2023, then grew 14.01% in 2024.
  • A 4-year view of Non-Current Deferred Tax Liability shows it stood at $22.9 million in 2022, then tumbled by 44.5% to $12.7 million in 2023, then increased by 8.55% to $13.8 million in 2024, then fell by 26.71% to $10.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Deferred Tax Liability were $10.1 million in Q3 2025, $11.5 million in Q2 2025, and $9.9 million in Q1 2025.